Nordicus Partners (NORD)
OTHER OTC:NORD
US Market
Holding NORD?
Track your performance easily

Nordicus Partners (NORD) Stock Price & Analysis

10 Followers

NORD Stock Chart & Stats


Financials

Annual

Options Prices

Currently, No data available
---

Ownership Overview

59.21%0.00%0.00%40.79%
59.21% Insiders
0.00% Other Institutional Investors
40.79% Public Companies and
Individual Investors

NORD FAQ

What was Nordicus Partners’s price range in the past 12 months?
Nordicus Partners lowest stock price was $0.40 and its highest was $0.90 in the past 12 months.
    What is Nordicus Partners’s market cap?
    Currently, no data Available
    When is Nordicus Partners’s upcoming earnings report date?
    Nordicus Partners’s upcoming earnings report date is Feb 14, 2018 which is 2417 days ago.
      How were Nordicus Partners’s earnings last quarter?
      Currently, no data Available
      Is Nordicus Partners overvalued?
      According to Wall Street analysts Nordicus Partners’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
        Does Nordicus Partners pay dividends?
        Nordicus Partners pays a Notavailable dividend of $0.25 which represents an annual dividend yield of N/A. See more information on Nordicus Partners dividends here
          What is Nordicus Partners’s EPS estimate?
          Nordicus Partners’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does Nordicus Partners have?
          Nordicus Partners has 49,622,250 shares outstanding.
            What happened to Nordicus Partners’s price movement after its last earnings report?
            Currently, no data Available
            Which hedge fund is a major shareholder of Nordicus Partners?
            Currently, no hedge funds are holding shares in NORD
            ---

            Nordicus Partners Stock Smart Score

            10
            Unlock Smart Score
            1
            2
            3
            4
            5
            6
            7
            8
            9
            10

            Company Description

            Nordicus Partners

            AdvanSource Biomaterials Corp. engages in the development of polymer materials, which provides characteristics in the design and development of medical devices. Its biomaterials are used in devices that are designed for treating a range of anatomical sites and disease states. The firm's products include ChronoFlex, ChronoSil, HydroMed, HydroThane, and PolyBlend. The company was founded in 1993 and is headquartered in Wilmington, MA.
            ---
            Similar Stocks
            Company
            Price & Change
            Follow
            GSE Systems
            Sow Good
            ADM Tronics Unlimited
            Popular Stocks
            ---
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis